NEW YORK, May 20 (GenomeWeb News) - Nineteen months after going out of business, microarray manufacturer Febit has re-emerged as a new company with fresh venture capital backing.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.